Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
biotech deals
Biotech
JPM26: All of the meetings, none of the megadeals
Hopes were high Wednesday for a billion-dollar megadeal—the kind JPM is known for—but no major deals ever materialized.
Gabrielle Masson
Jan 15, 2026 4:30am
AirNexis swoops in with $200M series A for COPD asset
Jan 9, 2026 11:01am
GSK inks model deal in $50M bet on Noetik's cancer AI platform
Jan 8, 2026 10:30am
InduPro nabs 2nd Big Pharma deal with $950M Lilly pact
Jan 7, 2026 3:52pm
Boehringer continues kidney dealmaking with $120M Variant pact
Jan 6, 2026 10:45am
Amgen weaves in UK biotech with up to $840M acquisition
Jan 6, 2026 10:35am
